Screening method for frizzled related proteins agonists and antagonists
CA 2729889 A1 · Owner: Alcon, Inc. · Inventors: Mcnatt, Loretta; Clark, Abbot F.; Fingert, John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods and compositions for diagnosing and treating glaucoma by detecting alterations in the Wnt signaling pathway-including changes in , the level or bioactivity of frizzled related protein. The invention further provides , methods for screening for anti-glaucomatous compounds by detecting a Wnt pathway , component such as a frizzled related protein as well as methods for , predicting or diagnosing glaucoma based upon the detection of a genetic alteration in a Wnt pathway component gene.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 26, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.